Sign in
Taking people in United StatesNo phase

Custom-modified stent grafts for complex aortic aneurysms near the kidney arteries

Tests doctor-modified stent grafts for aortic aneurysms in people at high surgical risk.

Key facts

Who runs it
Akhilesh Jain
Where
Hartford, United StatesSee the site
Trial code
Registry title
Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms
Status
Recruiting
People taking part
15 people, planned
Started
1 Jun 2025
Expected to end
1 May 2032
Type of study
Interventional
Treatments tested
  • Physician Modified Aortic Endograft repair for complex aortic aneurysm
Record updated
24 August 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a juxtarenal abdominal aortic aneurysm (a bulge in the main belly artery near the kidney arteries). They must be at high risk for open surgery and have few or no other approved device options. The trial tests stent grafts modified by the doctor.

Age
18 years or older
Sex
Men and women. Women cannot be pregnant. Women who could become pregnant need a negative pregnancy test before joining.
Disease stage
Juxtarenal aneurysm with at least one of these: diameter ≥ 5.5 cm (2.2 in) in men (≥ 5.0 cm (2 in) in women) or 2 times the normal artery diameter; growth > 0.5 cm (0.2 in) in 6 months; saccular aneurysm at significant risk of bursting; aneurysm causing symptoms; or burst (ruptured) aneurysm. The artery shape and size must fit the device, for example neck diameter between 20 and 32 mm and neck angle ≤ 60°.

Main reasons for not taking part

  • Infected aneurysm or active infection
  • Unstable angina (worsening chest pain)
  • Connective tissue disease of the aorta, such as Marfan's or Ehler's-Danlos syndrome
  • Life expectancy of less than 1 year
  • Can be treated with an FDA approved EVAR or FEVAR device and can wait for it, or can join a manufacturer-sponsored study

The registry criteria, word for word

Show all 26 criteriaShow less

Who can take part

  • Patient is ≥ 18 years of age
  • Patients who are male or non-pregnant female (females of child bearing potential must have a negative pregnancy test prior to enrollment into the study)
  • Patient or Legally Authorized Representative has signed an Institutional Review Board (IRB) approved Informed Consent Form
  • Patient has a juxtarenal abdominal aortic aneurysm that meets at least one of the following:; An aneurysm with a maximum diameter of ≥ 5.5 cm for male (≥ 5.0 cm for female) or 2 times the normal diameter just proximal to the aneurysm using orthogonal (i.e., perpendicular to the centerline) measurements; Aneurysm with a history of growth > 0.5 cm in 6 months; Saccular aneurysm deemed at significant risk for rupture; Symptomatic aneurysm; Ruptured aneurysm
  • Patient has patent iliac or femoral arteries, with or without the use of conduit, that will allow endovascular access with the physician modified endovascular graft
  • Patient has a suitable non-aneurysmal proximal aortic neck of ≥ 2 mm inferior to the most distal renal artery ostium
  • Patient has a suitable non-aneurysmal distal iliac artery length (seal zone) of ≥ 15mm. The resultant repair should preserve patency in at least one hypogastric artery
  • Patient has a suitable non-aneurysmal proximal aortic neck diameter between 20 and 32 mm, averaged across the diameters at the Celiac, SMA, at the lowest patent renal artery and at the midpoint of the renal arteries
  • Patient has suitable non-aneurysmal distal common iliac diameters between 8 and 20 mm
  • Patient has juxtarenal aortic neck angulation ≤ 60°
  • Target branch vessel diameter ≥ 5 mm
  • Patient must be willing to comply with all required follow-up exams

Who cannot take part

  • Patient has a major surgical or interventional procedure, not related to the endovascular repair, planned within +/- 30 days of the AAA repair
  • Patient is currently participating in another investigational device or drug clinical trial
  • Patient has other medical, social or psychological conditions that, in the opinion of the investigator, preclude them from receiving the pre-treatment, required treatment, and post-treatment procedures and evaluations
  • Patient has a mycotic aneurysm or has an active systemic or local infection that may increase the risk of endovascular infection
  • Patient has unstable angina (defined as angina with a progressive increase in symptoms, new onset at rest or nocturnal angina, or onset of prolonged angina)
  • Patient has history of an aortopathic connective tissue disease (e.g. Marfan's or Ehler's-Danlos syndrome)
  • Patient has a known hypersensitivity or contraindication to anticoagulation or contrast media that is not amenable to pre-treatment
  • Patient has known allergy or intolerance to stainless steel, nitiol, or gold (gold-plated tungsten)
  • Patient has a body habitus that would inhibit X-ray visualization of the aorta
  • Patient has a limited life expectancy of less than 1 year
  • Thrombus or excessive calcification within the neck of the aneurysm
  • Branch vessel stenosis ≥ 80 %
  • Patients treatable on label with FDA approved EVAR or FEVAR device and can wait for device availability
  • Subject is willing and eligible to enroll in a manufacturer-sponsored study at the investigational site, or the subject is willing and eligible to participate in a study with a manufacturer-made device at another institution; -

This trial is currently available in United States.

  • Hartford HospitalHartford, United StatesContact: Akhilesh K Jain, MD, FACS, FSVSTaking people

About the trial

What the trial wants to find out

The primary objective of the clinical investigation "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms" is to assess the use of the Physician-Modified Endovascular Grafts to repair juxtarenal aneurysms in high-risk subjects considered to be high risk candidates for open surgical repair, have limited or no other options for on label treatment with an FDA approved device, and having appropriate anatomy.

The group in the trial

  • Treatment armTreatment being tested

    Treatment: Physician Modified Aortic Endograft repair for complex aortic aneurysm

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms
Plain-language title
Custom-modified stent grafts for complex aortic aneurysms near the kidney arteriesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
24 August 2025